vpc23019 Search Results


90
MedChemExpress s1pr1 3 antagonist vpc23019
S1pr1 3 Antagonist Vpc23019, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/VPC+23019/pm35066669-39-12-15
Average 90 stars, based on 1 article reviews
s1pr1 3 antagonist vpc23019 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

N/A
VPC 23019(Cat No.:I010015)is a potent antagonist of sphingosine-1-phosphate (S1P) receptors, with selectivity for S1P₁ and S1P₃ subtypes. By blocking receptor-mediated signaling, it disrupts S1P-driven pathways that regulate lymphocyte trafficking, vascular tone, and cell survival. This
  Buy from Supplier

vpc  (Tocris)
93
Tocris vpc
Vpc, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/VPC+23019/pmc04981491-89-2-5
Average 93 stars, based on 1 article reviews
vpc - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Croda International Plc vpc23019
S1P bound to albumin induced PAI-1 expression by activating S1PR2 pathway in 3T3L1 adipocytes. (A) 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM and the medium was exchanged for FBS-free DMEM containing 20 µM of <t>VPC23019,</t> JTE013, or DMSO for 30 minutes. Then, the cells were challenged with a medium containing 10 µM of sphingosine 1-phosphate (S1P) with the corresponding inhibitors for 4 hours. The mRNA level of plasminogen activator inhibitor 1 (PAI-1) was analyzed using real-time PCR. 18S was utilized as an internal control ( n = 4–6/group). † p < 0.01 vs. DMSO alone, YC1 alone, S1P + VPC, and JTE alone, and p < 0.05 vs. S1P + JTE. ‡ p < 0.01 vs. other groups. (B, C). 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM, and the medium was exchanged for FBS-free DMEM with 10 µM of S1P bound to apoM-rich vehicle (ApoM) or control vehicle (Null) for 4 hours. Then, the modulation of the phosphorylation of moesin in 3T3L1 cells was examined using western blotting ( n = 6/group). ** p < 0.01, *** p < 0.001.
Vpc23019, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/VPC+23019/pmc05587522-38-0-2
Average 90 stars, based on 1 article reviews
vpc23019 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Tocris vpc23019
S1P bound to albumin induced PAI-1 expression by activating S1PR2 pathway in 3T3L1 adipocytes. (A) 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM and the medium was exchanged for FBS-free DMEM containing 20 µM of <t>VPC23019,</t> JTE013, or DMSO for 30 minutes. Then, the cells were challenged with a medium containing 10 µM of sphingosine 1-phosphate (S1P) with the corresponding inhibitors for 4 hours. The mRNA level of plasminogen activator inhibitor 1 (PAI-1) was analyzed using real-time PCR. 18S was utilized as an internal control ( n = 4–6/group). † p < 0.01 vs. DMSO alone, YC1 alone, S1P + VPC, and JTE alone, and p < 0.05 vs. S1P + JTE. ‡ p < 0.01 vs. other groups. (B, C). 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM, and the medium was exchanged for FBS-free DMEM with 10 µM of S1P bound to apoM-rich vehicle (ApoM) or control vehicle (Null) for 4 hours. Then, the modulation of the phosphorylation of moesin in 3T3L1 cells was examined using western blotting ( n = 6/group). ** p < 0.01, *** p < 0.001.
Vpc23019, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/VPC+23019/us12357622-73-3-9
Average 94 stars, based on 1 article reviews
vpc23019 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

97
Santa Cruz Biotechnology vpc2309
Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with <t>VPC2309</t> (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.
Vpc2309, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/VPC+23019/pmc12756306-51-1-5
Average 97 stars, based on 1 article reviews
vpc2309 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

90
Avanti Inc vpc23019
Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with <t>VPC2309</t> (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.
Vpc23019, supplied by Avanti Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/vpc23019/pmc03358576-76-9-10
Average 90 stars, based on 1 article reviews
vpc23019 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ApexBio s1pr1/3 inhibitor vpc23019
Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with <t>VPC2309</t> (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.
S1pr1/3 Inhibitor Vpc23019, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/s1pr1+3+inhibitor+vpc23019/pm38185885-57-1-7
Average 90 stars, based on 1 article reviews
s1pr1/3 inhibitor vpc23019 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biomol GmbH pertussis toxin vpc23019
Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with <t>VPC2309</t> (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.
Pertussis Toxin Vpc23019, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/pertussis+toxin+vpc23019/pm23328083-45-2-7
Average 90 stars, based on 1 article reviews
pertussis toxin vpc23019 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Hasegawa Co Ltd s1pr1
Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with <t>VPC2309</t> (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.
S1pr1, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vpc23019/antagonist+s1pr1+vpc23019/pm41064449-65-3-15
Average 86 stars, based on 1 article reviews
s1pr1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier


N/A
Sphingosine-1-phosphate (S1P) is a versatile signaling molecule, which is produced by phosphorylation of sphingosine by two distinct sphingosine kinases, SphK1 and SphK2. S1P binds to five G-protein coupled receptors designated S1P1-5 leading to cell proliferation,
  Buy from Supplier

Image Search Results


S1P bound to albumin induced PAI-1 expression by activating S1PR2 pathway in 3T3L1 adipocytes. (A) 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM and the medium was exchanged for FBS-free DMEM containing 20 µM of VPC23019, JTE013, or DMSO for 30 minutes. Then, the cells were challenged with a medium containing 10 µM of sphingosine 1-phosphate (S1P) with the corresponding inhibitors for 4 hours. The mRNA level of plasminogen activator inhibitor 1 (PAI-1) was analyzed using real-time PCR. 18S was utilized as an internal control ( n = 4–6/group). † p < 0.01 vs. DMSO alone, YC1 alone, S1P + VPC, and JTE alone, and p < 0.05 vs. S1P + JTE. ‡ p < 0.01 vs. other groups. (B, C). 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM, and the medium was exchanged for FBS-free DMEM with 10 µM of S1P bound to apoM-rich vehicle (ApoM) or control vehicle (Null) for 4 hours. Then, the modulation of the phosphorylation of moesin in 3T3L1 cells was examined using western blotting ( n = 6/group). ** p < 0.01, *** p < 0.001.

Journal: Journal of Atherosclerosis and Thrombosis

Article Title: Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression

doi: 10.5551/jat.37663

Figure Lengend Snippet: S1P bound to albumin induced PAI-1 expression by activating S1PR2 pathway in 3T3L1 adipocytes. (A) 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM and the medium was exchanged for FBS-free DMEM containing 20 µM of VPC23019, JTE013, or DMSO for 30 minutes. Then, the cells were challenged with a medium containing 10 µM of sphingosine 1-phosphate (S1P) with the corresponding inhibitors for 4 hours. The mRNA level of plasminogen activator inhibitor 1 (PAI-1) was analyzed using real-time PCR. 18S was utilized as an internal control ( n = 4–6/group). † p < 0.01 vs. DMSO alone, YC1 alone, S1P + VPC, and JTE alone, and p < 0.05 vs. S1P + JTE. ‡ p < 0.01 vs. other groups. (B, C). 3T3L1 adipocytes were pre-incubated for 18 hours in FBS-free DMEM, and the medium was exchanged for FBS-free DMEM with 10 µM of S1P bound to apoM-rich vehicle (ApoM) or control vehicle (Null) for 4 hours. Then, the modulation of the phosphorylation of moesin in 3T3L1 cells was examined using western blotting ( n = 6/group). ** p < 0.01, *** p < 0.001.

Article Snippet: VPC23019 (857360P; Avanti Polar Lipids, Alabaster, AL), JTE013 (10009458; Cayman Chemical, Ann Arbor, MI), Y27632 (257-00511; WAKO Pure Chemical Industries, Osaka, Japan), wortmannin, YC-1 (W1628, Y102; Sigma-Aldrich Co), and SIS3 and BAY11-7082 (sc-222318, sc-200615; Santa Cruz Biotechnology, Inc. TX) were dissolved in DMSO.

Techniques: Expressing, Incubation, Real-time Polymerase Chain Reaction, Control, Phospho-proteomics, Western Blot

Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with VPC2309 (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.

Journal: Scientific Reports

Article Title: Thymosin β4 stabilizes hypoxia induced brain microvascular endothelial cell dysfunction through S1PR1 dependent mechanisms

doi: 10.1038/s41598-025-28435-2

Figure Lengend Snippet: Effect of VPC23019 (a S1PR1 inhibitor) and Tβ4 on S1PR1 and SGPL1 gene expression in hBMVEC. hBMVECs were pretreated with VPC2309 (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) S1PR1 and ( B ) SGPL1 were measured using reverse transcription-quantitative PCR. ( C ) Representative image of the Western blot analysis of S1PR1 protein level. ( D ) Quantification of S1PR1 Western blot analysis. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.

Article Snippet: For VPC2309 (Cat no. sc-362817, Santa Cruz, USA), an inhibitor of S1PR1 treatment, the cells were pretreated with VPC2309 at a concentration of 50 nmol for 2 h prior to switching the cells in hypoxic chamber.

Techniques: Gene Expression, Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot

Effect of VPC23019 and Tβ4 on TJ genes expression in hBMVEC. hBMVECs were pretreated with VPC2309 (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) Occludin, ( B ) Cldn 5 and ( C ) Tjp1 were measured using reverse transcription-quantitative PCR. ( D ) Representative image of the Western blot analysis of Cldn 5 and Occludin protein level. ( E ) The quantification of Cldn 5 and ( F ) Occludin Westerns were shown. These experiments were replicated three times, and amplifications were performed and normalized to GAPDH. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.

Journal: Scientific Reports

Article Title: Thymosin β4 stabilizes hypoxia induced brain microvascular endothelial cell dysfunction through S1PR1 dependent mechanisms

doi: 10.1038/s41598-025-28435-2

Figure Lengend Snippet: Effect of VPC23019 and Tβ4 on TJ genes expression in hBMVEC. hBMVECs were pretreated with VPC2309 (50 nmol) for 2 h followed by 2 h with Tβ4 (1 μg/mL) and then was exposed to 2 h and 24 h hypoxia. The mRNA expression of ( A ) Occludin, ( B ) Cldn 5 and ( C ) Tjp1 were measured using reverse transcription-quantitative PCR. ( D ) Representative image of the Western blot analysis of Cldn 5 and Occludin protein level. ( E ) The quantification of Cldn 5 and ( F ) Occludin Westerns were shown. These experiments were replicated three times, and amplifications were performed and normalized to GAPDH. Results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells.

Article Snippet: For VPC2309 (Cat no. sc-362817, Santa Cruz, USA), an inhibitor of S1PR1 treatment, the cells were pretreated with VPC2309 at a concentration of 50 nmol for 2 h prior to switching the cells in hypoxic chamber.

Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot

Effect of VPC23019 and Tβ4 on hypoxia-induced hBMVECs monolayer permeability. Permeability assays were performed as described in legend of Fig. A. Cultured hBMVECs were pre-treated with VPC2309 for 2 h followed by 2 h Tβ4 (1 μg/mL) and subjected to 24 h hypoxia. The permeability results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells. hBMVECs, human brain microvascular endothelial cells.

Journal: Scientific Reports

Article Title: Thymosin β4 stabilizes hypoxia induced brain microvascular endothelial cell dysfunction through S1PR1 dependent mechanisms

doi: 10.1038/s41598-025-28435-2

Figure Lengend Snippet: Effect of VPC23019 and Tβ4 on hypoxia-induced hBMVECs monolayer permeability. Permeability assays were performed as described in legend of Fig. A. Cultured hBMVECs were pre-treated with VPC2309 for 2 h followed by 2 h Tβ4 (1 μg/mL) and subjected to 24 h hypoxia. The permeability results are presented as the mean ± SEM ( n = 3). * P < 0.05 vs. normoxia cells. # P < 0.05 vs. hypoxia cells. hBMVECs, human brain microvascular endothelial cells.

Article Snippet: For VPC2309 (Cat no. sc-362817, Santa Cruz, USA), an inhibitor of S1PR1 treatment, the cells were pretreated with VPC2309 at a concentration of 50 nmol for 2 h prior to switching the cells in hypoxic chamber.

Techniques: Permeability, Cell Culture